Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics


Oramed Pharmaceuticals Inc. (ORMP)

Today's Latest Price: $4.85 USD

0.00 (0.00%)

Updated Feb 14 12:00am

Add ORMP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

ORMP Stock Summary

  • Oramed Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 12.72% of US listed stocks.
  • For ORMP, its debt to operating expenses ratio is greater than that reported by only 8.16% of US equities we're observing.
  • ORMP's price/sales ratio is 33.86; that's higher than the P/S ratio of 95.95% of US stocks.
  • Stocks that are quantitatively similar to ORMP, based on their financial statements, market capitalization, and price volatility, are KALV, CNAT, RCUS, VNE, and MGEN.
  • ORMP's SEC filings can be seen here. And to visit Oramed Pharmaceuticals Inc's official web site, go to www.oramed.com.
ORMP Daily Price Range
ORMP 52-Week Price Range

ORMP Stock Price Chart More Charts


ORMP Price/Volume Stats

Current price $4.85 52-week high $6.05
Prev. close $4.85 52-week low $2.32
Day low $4.81 Volume 35,600
Day high $4.96 Avg. volume 107,803
50-day MA $5.12 Dividend yield N/A
200-day MA $3.74 Market Cap 86.27M

Oramed Pharmaceuticals Inc. (ORMP) Company Bio


Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.


ORMP Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ORMP Latest Social Stream


Loading social stream, please wait...

View Full ORMP Social Stream

ORMP Price Returns

1-mo -9.85%
3-mo 95.56%
6-mo 50.15%
1-year 49.23%
3-year -23.98%
5-year 10.48%
YTD -5.83%
2019 71.67%
2018 -66.67%
2017 47.06%
2016 -28.42%
2015 87.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6531 seconds.